Lesson 5.6 · about 12 minutes
Pharma and healthcare
- Past prices, at least 30 days old
- News or record
- Hypothetical
Learn to
- Separate US generics, domestic medicines and contract manufacturing
- Read a regulatory event without claiming it caused a move
- List other things that moved around the same date
Ideas in this lesson
- US generics
- Domestic formulations
- Contract manufacturing
- USFDA inspections
- Price erosion
- Active ingredients
Pharma has three broad parts. Generics makers supply copies of off-patent medicines, many of them to the US. Domestic companies sell branded medicines in India, where some prices are set by the government. Contract manufacturers make medicines for other companies. Healthcare adds hospitals and diagnostics. Each part has different drivers, so a headline about one may not touch the others.
For export sales the USFDA matters twice: it approves each product, and it inspects the plants. A list of faults can freeze approvals from a plant until they are fixed. Generics also face price erosion: as more makers launch the same product, its price falls, and a firm needs new launches to keep sales level.
Try it · past index levels and headlines as published
Open a headline about a US drug regulator, as published. Look at what the pharma and healthcare indices did in the sessions after its date against the broad market, and write down two other things that happened that week.
The sector on one page, under six headings: Pharma
- Defensive
- Both
- Part regulated
Teaching labels on past patterns, not market advice.
- 1. What it is
- Pharma and healthcare covers makers of medicines for India and for export (mainly generics to the US), contract manufacturers, hospitals and diagnostics.
- 2. What moves it
- A US inspector finds problems at a plant
- The rupee weakens against the dollar
- US prices of generic drugs fall
- 3. What to read
- Share of sales by region (India, US, rest)
- Plant inspection status
- Research spending as a share of sales
- Launches in the US
- Raw material (API) sourcing
- 4. Links to the economy
- 5. Risks and unknowns
- One inspection can change a company's outlook
- Domestic prices of many medicines are controlled
- Dependence on imported active ingredients
- 6. Who regulates it, and where the data comes from
CDSCO and the price authority NPPA in India; the US Food and Drug Administration for US sales.
Data: Company results, regulator notices and inspection records.
What moves it: choose a change, say what you expect, then open the model
Headlines about the US drug regulator, as published
Loading index history...
These are teaching models with invented numbers. They show how a change can travel and are not forecasts; real effects differ in size, speed and sometimes direction.
Loading index history...
The table shows what the indices did after a date and nothing about why. A single event is a weak test: many things happen around the same date, among them the market as a whole, the rupee, other news about the company, and results from its peers. Studying an event by lining up a date against a move is called an event study, and even a careful one needs many events to say anything.
These headlines are past events and are shown as published, with their publisher, date and a link to the original article. The lesson does not rank companies or say what a reader should do about any of them.
Check yourself
0 of 3 right
Answer every question correctly to complete this lesson.
Open it live
Lessons use prices at least 30 days old. The live pages show current ones.
Sources
Last reviewed 30 Oct 2026 by the author. Independent fact review is pending before public launch. Facts are as of the dates shown. Education only; not investment advice.